Filter
645
Text search:
viral
suppression
Featured
73
178
Language
Document type
343
123
102
23
20
16
8
5
1
1
1
Countries / Regions
32
27
25
18
18
18
16
16
14
12
11
11
8
8
7
7
7
7
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
276
50
19
7
4
2
2
1
Toolboxes
268
39
21
13
11
10
9
6
5
4
4
3
3
3
2
2
1
1
1
1
Providing quality, stigma-free services is essential to equitable health care for all and achieving global HIV goals and broader Sustainable Development Goals related to health. Every person has the right to the highest attainable standard of physical and mental health. Countries have a legal obliga
...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can ...
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can ...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can be
...
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
CDC leads an international surveillance effort to estimate the occurrence of HIV drug resistance among people with HIV who are taking dolutegravir (DTG)-based treatments. This surveillance effort utilizes Cyclical Acquired HIV Drug Resistance Surveillance (CADRE), a laboratory-based HIV drug resista
...
A job aid for cadres supporting adolescents living with HIV (ages 15-19) in Orphans and Vulnerable
Children (OVC) Programs
J Hepatol (2017), http://dx.doi.org/10.1016/j.jhep.2017.03.021
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care
...
Locate, test, treat and retain (L2TR) Ghana campaign. 90-90-90 ending the AIDS epedemic by 2030
Child Survival Working Group
Accessed: 18.10.2019
Accessed: 03.03.2020
